Champions Oncology (CSBR) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to 0.14.
- Champions Oncology's Equity Ratio rose 41990.64% to 0.14 in Q4 2025 from the same period last year, while for Oct 2025 it was 0.14, marking a year-over-year increase of 41990.64%. This contributed to the annual value of 0.12 for FY2025, which is 26014.44% up from last year.
- Per Champions Oncology's latest filing, its Equity Ratio stood at 0.14 for Q4 2025, which was up 41990.64% from 0.12 recorded in Q3 2025.
- Over the past 5 years, Champions Oncology's Equity Ratio peaked at 0.32 during Q1 2021, and registered a low of 0.08 during Q1 2024.
- Its 5-year average for Equity Ratio is 0.15, with a median of 0.16 in 2025.
- As far as peak fluctuations go, Champions Oncology's Equity Ratio tumbled by 15389.59% in 2024, and later surged by 96984.11% in 2025.
- Over the past 5 years, Champions Oncology's Equity Ratio (Quarter) stood at 0.28 in 2021, then fell by 8.45% to 0.25 in 2022, then tumbled by 98.7% to 0.0 in 2023, then soared by 720.86% to 0.03 in 2024, then surged by 419.91% to 0.14 in 2025.
- Its last three reported values are 0.14 in Q4 2025, 0.12 for Q3 2025, and 0.12 during Q2 2025.